The Greenrose Holding Company to Hold Second Quarter 2022 Conference Call on August 15, 2022 at 5:00 p.m. ET

The Greenrose Holding Company to Hold Second Quarter 2022 Conference Call on August 15, 2022 at 5:00 p.m. ET

The Greenrose Holding Company Inc. (OTC: GNRS, GNRSW) ("Greenrose" or the "Company"), a multi-state grower and producer of cannabis brands and products will hold a conference call on Monday, August 15, 2022, at 5:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2022. The Company will provide its financial results in a press release prior to the conference call.

Greenrose management will host the conference call, followed by a question-and-answer session.

Conference Call Date: August 15, 2022
Time: 5:00 p.m. Eastern time
Registration Link: https://register.vevent.com/register/BIf28abed85b5049a0b4c66781e778ec42

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at (949) 574-3860.

The conference call will be broadcast live and available for replay here .

About The Greenrose Holding Company Inc.
The Greenrose Holding Company Inc. is a multi-state cultivator and producer of cannabis brands and products. Greenrose is driven by cultivation. It is understood that being a leader in the cannabis industry starts with outstanding flower derived from sophisticated genetics and scalable grow methods. Greenrose aims to be a vertically integrated company that looks for scale and horizontal consolidation. For more information, please visit www.greenroseholdings.com .

Investor Relations Contact:
Gateway Group, Inc.
Cody Slach or Jackie Keshner
(949) 574-3860
GNRS@gatewayir.com

Greenrose Contact:
Daniel Harley
Executive Vice President, Investor Relations
(516) 307-0383
ir@greenroseholdings.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

GNRS
The Conversation (0)
Sona Provides Corporate Update on Operating Activities

Sona Provides Corporate Update on Operating Activities

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona"), a nanotechnology life sciences company with proprietary manufacturing technology for biocompatible gold nanorods ("GNRs"), is pleased to provide an update on the status of its current operating activities, notably the development of its Targeted Hyperthermia Therapy ("THT") therapy and its rapid bovine tuberculosis prototype test.

Sona CEO, David Regan, commented, "Earlier this year, Sona developed a plan to secure the FDA Investigational Device Exemption necessary to permit human trials for our THT therapy, which is the strategic priority for the Company. Thanks to our purpose-built, strengthened team, Sona has made significant advancements towards this goal and has reduced the number of 'unknowns' in our development program by working with leading, experienced advisors and partners. With these accomplishments, including the completion of a prototype of our next generation THT light device by Minnetronix Medical and the securing of a THT efficacy study in murine breast, melanoma and colorectal models, we now look forward to reporting back in the coming months on study results, preclinical and manufacturing partner selections, and regulatory updates. All of these deliverables will advance our mission to develop a treatment therapy for colorectal cancer sufferers with less collateral damage than happens under the current standard of care."

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
The Greenrose Holding Company Reports Second Quarter 2022 Results

The Greenrose Holding Company Reports Second Quarter 2022 Results

  • Continued Focus on Ramping Cultivation Capacity in Connecticut and Arizona
  • Progressing Into Second Half of 2022 with Strengthened Leadership Team
  • Provides Update on Full Year 2022 Guidance

The Greenrose Holding Company Inc. (OTC: GNRS, GNRSW) ("Greenrose" or the "Company"), a multi-state grower and producer of cannabis brands and products, is reporting financial and operating results for the second quarter ended June 30, 2022 .

Second Quarter 2022 Financial Summary (Non-GAAP)

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
The Greenrose Holding Company to Hold Rescheduled Second Quarter 2022 Conference Call on August 22, 2022 at 5:00 p.m. ET

The Greenrose Holding Company to Hold Rescheduled Second Quarter 2022 Conference Call on August 22, 2022 at 5:00 p.m. ET

The Greenrose Holding Company Inc. (OTC: GNRS, GNRSW) ("Greenrose" or the "Company"), a multi-state grower and producer of cannabis brands and products will hold its rescheduled conference call on Monday, August 22, 2022, at 5:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2022. The Company will provide its financial results in a press release prior to the conference call.

Greenrose management will host the conference call, followed by a question-and-answer session.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
The Greenrose Holding Company Postpones Second Quarter 2022 Conference Call, Originally Scheduled for August 15, 2022 at 5:00 p.m. ET

The Greenrose Holding Company Postpones Second Quarter 2022 Conference Call, Originally Scheduled for August 15, 2022 at 5:00 p.m. ET

The Greenrose Holding Company Inc. (OTC: GNRS, GNRSW) ("Greenrose" or the "Company"), a multi-state grower and producer of cannabis brands and products announced that it will be postponing its scheduled conference call on Monday, August 15, 2022, at 5:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2022.

Greenrose is committed to reporting its second quarter 2022 financial results and providing an update on timing for the rescheduled conference call as soon as practicable. The Company expects to issue revised call details once confirmed.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Cronos Group Inc. enters into agreement for the sale-leaseback of its Stayner, Ontario facility

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") today announced that its wholly owned subsidiary entered into an agreement (the "Sale Agreement") with Future Farmco Canada Inc. (the "Buyer"), a vertical farming company, for the sale and leaseback of its property located at 4491 Concession 12 Sunnidale Road, Stayner, Ontario, Canada, L0M 1S0 (the "Peace Naturals Campus"). Pursuant to the terms of the Sale Agreement, the Buyer has agreed to acquire the Peace Naturals Campus for C$23 million cash, subject to the terms and conditions set forth therein. The parties also plan to enter into a lease agreement upon closing for portions of the Peace Naturals Campus, ensuring continued operations.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
cannabis leaves, statue of liberty

Cannabis Weekly Round-Up: New York Aims to Ease Banking Barriers, Wisconsin Issues Pardons

Cannabis businesses in New York are set to receive easier access to banking services.

Meanwhile, Wisconsin's governor was in a giving mood this week — ahead of the Thanksgiving holiday, he granted pardons to dozens of people with with cannabis-related convictions.

Read on to learn what else happened in the cannabis space this week.

Keep reading...Show less
Emyria Limited

Eminent Healthcare Leader Appointed as Independent Non-Executive Chairman for Emyria Ltd

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) focused on developing innovative treatments for mental health and neurological conditions, is pleased to announce the appointment of Greg Hutchinson as Independent Non-Executive Chairman.

Keep reading...Show less

Goodness Growth Holdings Announces Third Quarter 2023 Results

Q3 revenue of $24.7 million increased 44.0% YoY and 28.2% sequentially excluding discontinued operations –

– Stronger revenue growth and margins largely driven by adult-use activation in Maryland –

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Melodiol Global Health Limited

Capital Raising Re-Price & Prospectus Offers Extension

Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) provides an update to its previously announced capital raise and debt conversions (refer to ASX announcement dated 26 October 2023). In an effort to accelerate the receipt of funds, the Company has re-priced the issue price per fully paid ordinary share ('Shares’) for the capital raise from $0.005 to $0.002904. Under the new issue price, the Company advises that it has received firm commitments to raise approximately $1m (before costs) through the issue of approximately 348,108,292 new Shares (the ‘Revised Placement’). Additionally, the Company has also re-negotiated and agreed with creditors to convert $284,454 of amounts outstanding to equity, via the issuance of 108,743,113 Shares at an issue price of $0.002904 per Share (instead of $0.005 per Share), being on the same terms as the Revised Placement (‘Revised Debt Conversions').

Keep reading...Show less
ohio flag with gavel

Cannabis Weekly Round-Up: Ohio Legalizes Adult-use Cannabis, Aurora and Canopy Release Results

Ohio has officially become the latest US state to allow recreational cannabis for adult users.

Meanwhile, a survey conducted by a leading financial research firm suggests that investors feel optimistic that cannabis will be rescheduled in the US. And in Canada, quarterly results show two cannabis producers are seeing some relief.

Read on to learn what else happened in the cannabis space this week.

Keep reading...Show less

Latest Press Releases

Related News

×